期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Effect of Dexmedetomidine and Remifentanil on Renal Function in Patients Undergoing Bariatric Surgery 被引量:2
1
作者 Antonio Carlos Meinberg Joao Pedro Raduan Meinberg1] +7 位作者 Nathalia Simoes Artibale1] Pedro Thadeu Galvao Vianna1] Idiberto Jose Zotarelli Filho Discipline of Anesthesiology School of Medicine of Sao Jose do Rio Preto FAMERP Sao Jose do Rio Preto/SP Brazil 《Open Journal of Anesthesiology》 2020年第4期120-133,共14页
Background and Objectives: In anesthesia for bariatric surgery, alterations occur in several organs, including the kidney. The objective of this study was to compare the effect of dexmedetomidine and remifentanil on t... Background and Objectives: In anesthesia for bariatric surgery, alterations occur in several organs, including the kidney. The objective of this study was to compare the effect of dexmedetomidine and remifentanil on the renal function of morbidly obese patients submitted to bariatric surgery. Methods: Sixty-one patients were studied prospectively and divided randomly into two groups: remifentanil (R) and dexmedetomidine (D). Renal function was evaluated in three phases: before anesthesia (M0), after anesthetic induction (M1) and after surgical incision (M2). Plasma concentrations were determined for glucose, antidiuretic hormone, creatinine, urea, sodium, potassium and osmolarity and urinary concentrations for creatinine, urea, sodium, potassium and osmolarity. Results: Significant differences were found between groups for potassium at M1 (p Conclusions: In both groups, the clearance values fell from moments M0 to M2. This result indicates that renal function of obese patients submitted to bariatric surgery presented a physiological response compatible with the effect of anesthetic-surgical stress. In the group D, creatinine and sodium clearances were elevated at M1. Urinary volume was greater at M2. These results are suggestive of better preservation of renal function. 展开更多
关键词 Renal Function Bariatric Surgery DEXMEDETOMIDINE REMIFENTANIL
下载PDF
Approaches on the Major Predictors of Blood Transfusion in Cardiovascular Surgery: A Systematic Review
2
作者 Maria Christiane Valéria Braga Braile-Sternieri Eliana Migliorini Mustafa +7 位作者 Victor Rodrigues Ribeiro Ferreira Sofia Braile Sabino Cibele Olegário Vianna Queiroz Bethina Canaroli Sbardellini Giovanni Braile Sternieri Lúcia Angélica Buffulin de Faria Idiberto José Zotarelli Filho Domingo Marcolino Braile 《Health》 2019年第4期371-379,共9页
Introduction: Experimental Clinical studies have shown that loss of up to 77.0% of red cell mass can be tolerated as long as it kept the blood volume. However, the blood volume loss of about 34.0% is fatal. The initia... Introduction: Experimental Clinical studies have shown that loss of up to 77.0% of red cell mass can be tolerated as long as it kept the blood volume. However, the blood volume loss of about 34.0% is fatal. The initial attention in patients with bleeding should be given to maintaining blood volume and oxygen transport. Thus, transfusions of allogeneic blood products are associated with an increased risk of morbidity and mortality in cardiac surgery. Some transfusion risk scores have been proposed for cardiac surgery patients. Objective: To review and discuss literature blood transfusion (blood components gradient) in cardiovascular surgery versus polytrauma, gastrointestinal bleeding, and neoplastic diseases. Methods: The model followed for the review was PRISMA. We used the databases as Scielo, Lilacs, Google Scholar, PubMed articles and works of scientific and doctoral theses master. Results: According to the discussion in the literature, the acute bleeding of large volumes is challenging to emergency services. Accordingly, the need to support hemotherapeutics led to the development of protocols for more rational utilization of the monitored blood components. Conclusion: Hemotherapy services have adopted a very dynamic approach to the clinical condition presented by patients, the need for four or more red blood cell units. 展开更多
关键词 CARDIOVASCULAR Surgery POLYTRAUMA TRANSFUSION Blood Components Survival EPIDEMIOLOGIC Data Time to HEMOSTASIS Derivatives Volume
下载PDF
Analysis of the Risks of Development Injury Related to Surgical Positioning in a University Hospital of the State of Goiás/Brazil: An Observational-Epidemiological Study
3
作者 Bárbara Almeida Lemes Barbara Correia Neves Sabino +8 位作者 Carlos Eduardo Carvalho Sabino Ana Clara Lenza Martins Ana Letícia Neller Finta André Vinícius de Oliveira Mariana Cordeiro Carvalho Carolina Veras Mendes Giulia Ugucioni Garbelini Lara Cândida de Sousa Machado Idiberto José Zotarelli Filho 《Health》 2020年第7期876-890,共15页
<strong>Introduction:</strong> The perioperative nurse plays an important role throughout the surgical period, especially in the context of predicting the risks to which patients are exposed when entering ... <strong>Introduction:</strong> The perioperative nurse plays an important role throughout the surgical period, especially in the context of predicting the risks to which patients are exposed when entering a surgical center. These can be skin, muscle, tendon, and even burn injuries from the scalpel or chemicals. <strong>Objective:</strong> The aim of this study was to verify the degree of risk for the development of injuries resulting from surgical positioning in patients of a university hospital. <strong>Methods:</strong> This is cross-sectional, exploratory research with a quantitative approach conducted with 70 surgical patients in a Municipal University Hospital with data collection through a socioeconomic and health questionnaire and the Risk Assessment Scale for Development of Surgical Positioning Injuries (SISP). Statistical analyses included simple descriptive evaluation, correlations of variables using the Chi-square test and Pearson’s coefficient with a significance level of 5%. <strong>Results: </strong>The results found pointed to a population mainly composed of women (60%), married, with an average age of 49 years, with hypertension and high-risk scores to develop injuries due to surgical positioning. There was also a positive and significant correlation between having hypertension and having a higher risk of developing lesions, with R<sup>2</sup> = 96.4% and p < 0.05.<strong> Conclusion:</strong> The results reinforce the need to implement protocols and the acquisition of materials aimed at reducing the risk of injuries related to surgical positioning in order to improve the quality of care offered and thus minimize the harm to users. 展开更多
关键词 NURSING Pressure Injury Operating Room
下载PDF
Macrolide-Clarithromycin Task-Force for the Treatment and Prophylaxis of Covid-19 as a Single Agent
4
作者 Eduardo Mansilla Ricardo Rangel Martínez +6 位作者 Gustavo Horacio Marín Idiberto Zotarelli Filho Elsa Rivas Jaime Rivas Katherine Athayde Teixeira de Carvalho Mohammad Reza Dayer Alí Samadikuchaksaraei 《Pharmacology & Pharmacy》 2020年第6期85-104,共20页
SARS-CoV-2 is a novel RNA coronavirus responsible of a deadly pandemic: the clinical illness COVID-19. With only one authorized drug for emergency use in critically ill patients: Remdesivir, there is not any other app... SARS-CoV-2 is a novel RNA coronavirus responsible of a deadly pandemic: the clinical illness COVID-19. With only one authorized drug for emergency use in critically ill patients: Remdesivir, there is not any other approved drug or vaccine yet with proven potential to overcome this infection. We exposed here many scientific evidences to support our novel idea that a macrolide, basically Clarithromycin, could be effective as a single agent for treatment and prophylaxis of COVID-19. Clarithromycin could change the history of this pandemic. It could reduce the costs of treatment and the potential adverse effects when combining more than one drug such as with Hydroxychloroquine. Clarithromycin treatment and prophylaxis as a single agent could be much more simple, safe and cheaper as giving Chloroquine or Hydroxychloroquine alone or in combination with Azithromycin as well as other therapeutic options. 展开更多
关键词 COVID-19 MACROLIDES CLARITHROMYCIN Single Agent Therapy PROPHYLAXIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部